Background: Cisplatin is an effective chemotherapeutic agent used in treatment of solid tumors. Cardiotoxicity is one of the major side effect frequently observed after administration of cisplatin. Quercetin, an important dietary flavonoid present in several fruits and vegetables, exhibits antioxidant, antiinflammatory and anti-cancer properties.
Introduction
CISPLATIN is an effective chemotherapeutic agent used in treatment of solid tumors of the lung, ovary, testis as well as hematological malignancies [1] . Various studies reported many clinical finding in the heart after cisplatin administration these findings including electrocardiographic changes, arrhythmia, cardiomyopathy and congestive heart failure [2] .
Chirino and Pedraza-Chaverri, [3] reported that free oxygen radicals resulted from cisplatin administration play an important role in inducing toxicity. Free oxygen radicals induced by cisplatin produce cellular injury and necrosis via several mechanisms including peroxidation of membrane lipids and proteins and damage of DNA [4] . Devrim et al., [5] and Kuhed et al., [6] reported that in cisplatin treated animals, there was a decrease of the antioxidant enzyme activites (superoxide dismutase, catalase and glutathione perioxidase). All these mechanisms greatly encourage the using of free radical scavengers and antioxidants to counteract cisplatin-induced toxicities [7, 8] .
Quercetin (3, 3' ,4' , 5, 7-pentahydroxyflavone) , an important dietary flavonoid present in several fruits and vegetables, exhibits antioxidant, antiinflammatory and anti-cancer properties [9] . Quercetin scavenges superoxide anion, singlet oxygen and lipid peroxy radicals [10, 11] and inhibits coppercatalysed oxidation [12] . Several reports demonstrate that quercetin scavenges Reactive Oxygen Species (ROS)-induced cardiomyopathy [13, 14] . Furthermore,quercetin protects cardiomyocytes from the oxidative stress induced by H 2 O 2 through its antioxidant activity and it modulates the apoptosis signal transduction pathway [14] . Quercetin was more effective than other flavonoids such as 395 396 Possible Prophylactic Role of Querctine on Cisplatin-Induced Myocardial Toxicity naringenin, pycnogenol and trolox, in protecting against daunorubicin-induced cytotoxicity in cardiomyocytes [15] . The present study was performed to elucidate the prophylactic role of querectin in ameliorating the cisplatine induced cardiotoxicity.
The aim of this study was planed to monitor the histological and ultrastructural changes in the myocardium of adult male albino rats following administration of cisplatin and evaluate the possible cardioprotective effect of qurectine against experimental cardiotoxicity induced by cisplatin.
Material and Methods

Chemicals:
Cisplatin, in the form of powder, obtained from Bristol-Myers Squibb Company, Each vial containing 10mg and was given by intraperitonal injection at a dose of 15mg/kg body weight [16] , solution of of cisplatin was perepared by dilution of 15mg in 5ml normal saline to get final concentration 3 mg/ml. Quercetin powder was obtained from Sigma Chemical Company (St. Louis, MO, USA) and was diluted with 20% glycerol in 0.9% normal saline and stored in a dark bottle at 4ºC. The quercetin solution was freshly prepared each week and was given by gavages at a dose 30mg/kg body weight [17] . 30mg of qurecetine was diluted in 5ml (20% glycerol in 0.9% normal saline to get final concentration of 6mg/ml.
Animals:
Forty adult male albino rats (Sprague Dawly) weighing 180-200g were used in the ingoing study. They were obtained from the Animal House, June 2017-Dec. 2017, Faculty of Medicine, Cairo University. The animals were maintained in spacious wire mesh cages, each contained four rats with direct day light and natural ventilation at room temperature and allowed water and food ad libitum. All the animals were treated in accordance to the institutional guidelines for the care and use of laboratory animals.
Experimental design:
The rats were divided into 4 groups (n=10 each):
Group I: Normal control group. (Received nothing).
Group II (sham control):
Received a daily oral dose of one ml of normal saline via gastric gavage.
Group III: Received intraperitoneal single injection of cisplatin at 15mg/kg dose on the eighth day [16] .
Group IV: Querectine has been orally administered at 30mg/kg/day dose for one month beginning seven days prior to single cisplatin injection [17] .
After one month from the beginning of the experiment the animals were scarified by over dose of intravenous injection of Phenoparbital 100mg/kg. Then heart specimens (from the left ventricle) were taken from rats of all groups and subjected to the flowing studies.
I-Light microscopic study: Specimens were fixed in 10% buffered formol saline and processed for paraffin sections of 5-7 µm thickness, mounted on glass slides. Other sections were mounted on +ve charged slides for immunohistochemistry.
These sections were subjected to the following: 1-H & E and Masson's trichrome stain.
2-Immunohistochemichal staining for alpha smooth muscle actin (ct -SMA).
Primary antibody: Actin, Smooth Muscle Ab-1 (Clone 1A4):
It is a Mouse Monoclonal Antibody (Novocastra Lyphilized Corporation laboratories, UK, catalogue number NCL-SMA). It was supplied as (7.0ml) of antibody (200ug/ml) prediluted in 0.05mol/L Tris-HCl, pH 7.6 containing stabilizing protein and 0.015mol/L sodium azide. It was stored at 2-8ºC. No special pretreatment was required for immunohistochemical staining of formalin-fixed tissues.
Detection system for antibody:
Histostain SP kit (LAB-SA system, Zymed Laboratories Inc, San Francisco, CA 94080, USA, catalogue number 95-9643). It is a broad spectrum detection system that reacts with mouse, rabbit, guinea pig and rat primary antibody. This Histostain SP kit included serum blocking solution, a biotinylated secondary antibody, a horseradish peroxidase streptavidin and a substrate chromogen mixture to demonstrate antigen in cells and tissue.
Histomorphometric study: Using Leica image analysis computer system (soft ware Qwin 500), the following parameters were measured: A-Area % of collagen fibers in Masson's Trichrome stained sections was examined by magnification X400 and measured within a field of standard measuring frame this was done in 10 non overlapping microscopic fields of each specimen and their mean values were obtained and subjected to statistical analysis.
B-Area % of immune reaction of ct -SMA: Area % was measured for degree of immune reaction of α -SMA in anti-α -SMA stained sections using an objective lens of magnification 40 x i. e. a total magnification X400 in 10 random non overlapping fields in each section, inside a standard measuring frame of area (116964.91 µ m 2 ). The total and mean values were obtained and subjected to statistical analysis.
II-Electron microscopic study: Small pieces of the left ventricle was fixed in glutaraledhyde (PH 7.4) in phosphate buffer for 24 hours and post fixed in 2% osmium tetra oxide in phosphate buffer for one hour. Ultrathin sections (80-90) were stained by uranyl acetate and lead acetate. Processing was done in TEM lab-National Cancer Institute (NCI).
III-Statistical analysis:
The Statistical Package for the Social Science (SPSS) was used for data analysis. The data obtained were summarized as means and standard deviations and compared using one way analysis of variance (ANOVA). p-values <0.05 was considered statistically significant, while p<0.01 was considered statistically highly significant.
Results
Light microscopic results: Hematoxylin and Eosin results: Group I and Group II (normal and sham control group):
Light microscope examination of both control and sham control groups revealed similar histological picture; the muscle fibers appeared branching and anastomosing running in different directions. The cardiac myocyte exhidited one or more oval to rounded vesicular nucleus adjoining the cell surface membrane. Also flat fibroblast with spindle shaped nucleus was found in the interstitial tissue Fig. (1) .
Group III (cisplatin treated group):
Animal specimens of this group revealed histological changes in the form of loss of branching and anastomosing pattern of myocardium and complete loss of normal architecture of myocardium with widening of spaces of variable sizes inbetween muscle fibers Fig. (2) . Mononuclear cellular infiltration, rupture of muscle membrane with extrusion of nucleus outside were appeared. Vascular changes in the form of dilated capillary, engorged blood vessel and extravasation of red blood cells were also encountered Fig. (3) .
Group IV (cisplatin and qurecetine treated group):
Most of the myocardium in H & E sections from rats of this group appeared nearly normal as that in the control group. On other hand, some cardiac muscle fibers appeared slightly disorganized with mild spacing. Few pyknotic nuclei were encountered Fig. (4) .
Masson's trichrome results:
Group I and Group II (normal and sham control group):
Masson's trichrome sections illustrated minimal amount of collagen in-between the cardiac muscle fibers, mainly around blood vessels Fig. (5) .
Group III (cisplatin treated group):
Masson's trichrome sections showed increase in collagen deposition around engorged dilated blood vessel Fig. (6) .
Group IV (cisplatin and querectine treated group):
Masson's trichrome sections revealed minimal collagen fibers were seen in-between myocardial fibers compared with the Group III Fig. (7) .
Immunohistochemical results: Group I and Group II (control and sham control groups):
Examination of the left ventricular sections of the control group stained with anti-α -smooth muscle actin antibody revealed negative immunoreactivity in the myocardium Fig. (8) .
Group III (cisplatin treated group):
Myocardial sections of the cisplatin group (Group III) stained with anti-α -smooth muscle actin antibody showed positive immunoreactivity in the branched myofibroblasts Fig. (9) .
Group IV (cisplatin and querectine group):
Myocardial sections of the Group IV stained with anti-α -smooth muscle actin antibody showed minimal positive immunoreactivity in the myofibroblasts and in the smooth muscle fibers of the blood vessels Fig. (10) .
Electrone microscopic results: Group I and Group II (normal and sham control group):
Ultra structural examination showed normal structure of cardiomyocytes in the form of vesicular euchromatic nuclei and abundant electron dense mitochondria with normal cristal pattern, Z lines (line of meeting of actin and myosin filaments) were demonstrated Fig. (11) .
Group III (cisplatin treated group):
Electron microscopic examination showed disruption and vaculotion of myofibrils, the nuclei of cardiomyocyte showed marginated nuclear chromatin. Mitochondria showed variability in size and shape, enlargement (ballooning) with disturbed cristal pattern Figs. (12, 13) .
Group IV (cisplatin and querectine treated group):
Ultrastructural examination showed almost the same histological picture as with of the control group regarding the architecture of myocardium with demarcated Z lines and normal euchromatice nucleus with nucleolus inside. Mitochondria appear normal with intact cristae Fig. (14) .
Histomorphometric and statistical results:
A-Statistical study of the mean area percentage of collagen fibers: The mean area percentage of the collagen fibers of Group III showed highly significant increase in its value (p≤0.01) compared with the corresponding control group. The mean value of the area percentage of the collagen fibers of Group III increased significantly in comparison with Group IV. There was statistically significant difference between Group I and Group IV (Tables 1) and Histogram (1).
B-Statistical study of the area % of immune reaction of α SMA: The mean area % of α -SMA immunopositive cells showed no significant difference among the control group (Group I), (Group II). While the cisplatin treated group (Group III) resulted in significant increase (p< 0.05) in the mean area % of the α -SMA immunoreactivity as compared to Groups I, II & IV.
There was statistically significant difference between Group I and Group IV (Tables 1) and
Histogram (1). 
Discussion
Cisplatin induced cardiotoxic effects including: Angina [16] , acute myocardial infarction [17] , thromboembolic events [18] , hypertension [19] , myocarditis, pericarditis and severe congestive cardiomyopathy [21] . This cardiotoxic effects can be range from simple ECG changes to death [20] . Clinical usage of cisplatin as an anti-tumoral agent was restricted due to increased amount of oxidative stress and apoptosis related to cardiotoxicity [21] .
It has been established that excessive oxidative stress caused by either increased ROS production or inadequate antioxidant defense can lead to cardiac lesions [22] .
It was demonstrated that cisplatin induces morphological and functional alterations in the heart leading to myocardial necrosis [23, 24] , similar observation was seen in the present work following cisplatin injection in the form of loss of branching and anastomosing pattern of myocardium, widening of spaces in-between muscle fibers and mononuclear cellular infiltration.
The reactive free radicals have the potential to injure the cardiomyocytes directly and may be also involved in triggering inflammatory cascades through the induction of cytokines regulating leucocyte trafficking [22] , such finding could explain some of the mononuclear cell infiltrations seen following cisplatin injection.
In the current study, in cisplatin treated group using Masson trichrome stain there was an increase in collagen deposition around engorged dilated blood vessel and some collagen fibres appear inbetween myocardial fibers. These findings was confirmed by increased alpha smooth muscle actin expression. In the present study, electrone microscopic examinations of cisplatin treated group revealed focal disruption of myofibrils, variability in size and shape of some mitochondria which appeared swollen, with disturbed cristal pattern. Nuclear changes were in the form of vacuolations with clogged marginated nuclear chromatine, electrolucent areas in nucleus. These was in agreement of Ma et al., [25] who reported that depressed cardiomyocyte contraction and mitochondrial abnormalities, increased endoplasmic reticulum stress and associated apoptosis caused cardiac damage following cisplatin treatment. In addition cardiomyocytes containing numerous mitochondria constitute an important site for cisplatin accumulation and this condition eventually can lead to mitochondrial DNA damage [26] . Pretreatment with qurectine in cisplatin treated rats reversed the cisplatin induced alterations in lipid metabolism. Qurectine was reported to augment the endogenous antioxidants, which is an important event that protects the heart and endothelial cells from oxidative injury. It is already reported that Qurectine is the potent scavenger of ROS and antilipoperoxidative agent that inhibits the oxidation of LDL-C, which prevent endothelial cell injury induced by oxidized LDL-C [27] . In myofibril impairment observation, no significant difference has been observed between control and qurectine pre-treated groups. This histological finding indicates that qurectine is capable of preventing the myofibril damage induced by cisplatine. Therefore, it may be suggested that qurectine might inhibit cisplatin-induced cardiac damage.
The following mechanisms have been proposed for the antioxidant effects of qurectine: [1] Being a direct antioxidant, Qurectine could quench and detox-ify several reactive intermediates, like hypochlorous acid (HOCl) generated by myeloperoxidase, nitric oxide, H2O2, and hydroxyl radical, [2] . As an indirect antioxidant, qurectine could prevent the changes in membrane permeability due to oxidative injury via intercalating into the membrane and stabilizing it [28] . Renugadevi and Miltonprabu [29] reported that the membrane stabilizing effect of qurectine was linked to an action on permeability of ions and water.
Conclusion:
This study demonstrated that querectine had a significant effect in protection of the heart against myocardial histological changes induced by cisplatin.
